Search Results - "Millares, Mirta"

Association Between Exposure to Topical Tacrolimus or Pimecrolimus and Cancers by Hui, Rita L, Lide, William, Chan, James, Schottinger, Joanne, Yoshinaga, Monica, Millares, Mirta

“…Background: The Food and Drug Administration has issued a public health advisory regarding cancer risk from topical calcineurin inhibitors. Objective: To…”
Get full text

Diabetic Peripheral Neuropathic Pain: Is Gabapentin Effective? by Hyatt, Joel D., MD, FAAFP, Daniel, Dale, MD, FACS, Tran, Quynhlam V., PharmD, Millares, Mirta, PharmD, FCSHP, FASHP, Kubota, Debbie R., PharmD

“…During discovery in a lawsuit filed in federal court, it was learned that the manufacturers of Neurontin systematically biased scientific evidence through data…”
Get full text

Comparative effectiveness of first-line chemotherapies in advanced non-small cell lung cancer by Chang, Jennifer T., Spence, Michele M., Hui, Rita L., Schottinger, Joanne E., Rashid, Nazia, Millares, Mirta

“…Abstract only 293 Background: There is a variety of chemotherapy regimens used as first-line treatment in advanced non-small cell lung cancer (NSCLC). Few…”
Get full text

Evaluation of Dipeptidyl Peptidase-4 Inhibitors versus Thiazolidinediones or Insulin in Patients with Type 2 Diabetes Uncontrolled with Metformin and a Sulfonylurea in a Real-World Setting by Aboubechara, Natalie, Ledesma, Vittoria Marie, Niu, Fang, Lee, Susan M, Patel, Yesha A, Millares, Mirta, Hui, Rita L

“…Guidelines do not make clear recommendations for third add-on agents to metformin plus a sulfonylurea. This study compared the effectiveness and safety of…”
Get full text

ASHP guidelines on the pharmacy and therapeutics committee and the formulary system by Tyler, Linda S, Cole, Sabrina W, May, J Russell, Millares, Mirta, Valentino, Michael A, Vermeulen, Jr, Lee C, Wilson, Andrew L

Get full text

Treatment Patterns and Overall Survival Associated with First-Line Systemic Therapy for Patients with Advanced Non-Small Cell Lung Cancer by Spence, Michele M, Hui, Rita L, Chang, Jennifer T, Schottinger, Joanne E, Millares, Mirta, Rashid, Nazia

“…A variety of regimens are used as first-line treatment in patients with advanced non-small cell lung cancer (NSCLC), which may include combination regimens and…”
Get full text

Evaluation of Outcomes After Initiating Triple Antidiabetic Therapy with a GLP-1 RA in an Integrated Health Care System by Lee, Susan M, Aboubechara, Natalie, Niu, Fang, Ledesma, Vittoria Marie, Patel, Yesha A, Millares, Mirta, Hui, Rita L

“…Type 2 diabetes (T2D) is characterized by chronic hyper-glycemia and can lead to life-threatening complications if not treated. A stepwise and patient-centered…”
Get full text

Evaluation of Dipeptidyl Peptidase-4 Inhibitors versus Thiazolidinediones or Insulin in Patients with Type 2 Diabetes Uncontrolled with Metformin and a Sulfonylurea in a Real-World Setting by Aboubechara, Natalie, Ledesma, Vittoria Marie, Niu, Fang, Lee, Susan M, Patel, Yesha A, Millares, Mirta, Hui, Rita L

“…Guidelines do not make clear recommendations for third add-on agents to metformin plus a sulfonylurea. This study compared the effectiveness and safety of…”
Get full text

Identifying Subsequent Therapies in Patients with Advanced Non-Small Cell Lung Cancer and Factors Associated with Overall Survival by Afanasjeva, Janna, Hui, Rita L., Spence, Michele M., Chang, Jennifer, Schottinger, Joanne E., Millares, Mirta, Rashid, Nazia

“…Study Objectives To identify subsequent therapies used after first‐line therapies in patients with advanced non–small cell lung cancer (NSCLC), compare overall…”
Get full text

Kaiser Permanente's Evaluation And Management Of Biotech Drugs: Assessing, Measuring, And Affecting Use by Monroe, C. Douglas, Potter, Lori, Millares, Mirta, Barrueta, Anthony, Wagner, Richard

“…Two decades into the age of high-cost biotechnology medications, health care organizations are challenged to provide safe, effective treatment while managing…”
Get full text

Direct-to-Consumer Advertising of COX-2 Inhibitors: Effect on Appropriateness of Prescribing by Spence, Michele M., Teleki, Stephanie S., Cheetham, T. Craig, Schweitzer, Stuart O., Millares, Mirta

“…Spending on direct-to-consumer advertising (DTCA) of prescription drugs has increased dramatically in the past several years. An unresolved question is whether…”
Get full text

Kaiser Permanente's prescription drug benefit by Levine, S, Campen, D, Millares, M, Barrueta, A

“…The elements of its integrated delivery system - a mutually exclusive relationship between a group practice of self-governed physicians and a facility-based…”
Get full text

Kaiser Permanente's Prescription Drug Benefit: A look at how the HMO giant responds to unregulated market pricing of pharmaceuticals by Levine, Sharon, Campen, David, Millares, Mirta, Barrueta, Anthony

Get full text

Antibiotic prophylaxis in dental procedures by Ballard, C, Mowers, R M, Millares, M

Get more information

Extender device adaptability with metered-dose inhalers by Madrazo, G, Millares, M, VanRiper, K

Get more information